Cargando…

The Advances in Epigenetics for Cancer Radiotherapy

Cancer is an important factor threatening human life and health; in recent years, its morbidity and mortality remain high and demosntrate an upward trend. It is of great significance to study its pathogenesis and targeted therapy. As the complex mechanisms of epigenetic modification has been increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuexuan, Han, Yu, Jin, Yuzhen, He, Qiang, Wang, Zhicheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145982/
https://www.ncbi.nlm.nih.gov/pubmed/35628460
http://dx.doi.org/10.3390/ijms23105654
_version_ 1784716448590987264
author Wang, Yuexuan
Han, Yu
Jin, Yuzhen
He, Qiang
Wang, Zhicheng
author_facet Wang, Yuexuan
Han, Yu
Jin, Yuzhen
He, Qiang
Wang, Zhicheng
author_sort Wang, Yuexuan
collection PubMed
description Cancer is an important factor threatening human life and health; in recent years, its morbidity and mortality remain high and demosntrate an upward trend. It is of great significance to study its pathogenesis and targeted therapy. As the complex mechanisms of epigenetic modification has been increasingly discovered, they are more closely related to the occurrence and development of cancer. As a reversible response, epigenetic modification is of great significance for the improvement of classical therapeutic measures and the discovery of new therapeutic targets. It has become a research focusto explore the multi-level mechanisms of RNA, DNA, chromatin and proteins. As an important means of cancer treatment, radiotherapy has made great progress in technology, methods, means and targeted sensitization after years of rapid development, and even research on radiotherapy based on epigenetic modification is rampant. A series of epigenetic effects of radiation on DNA methylation, histone modification, chromosome remodeling, RNA modification and non-coding RNA during radiotherapy affects the therapeutic effects and prognosis. Starting from the epigenetic mechanism of tumorigenesis, this paper reviews the latest progress in the mechanism of interaction between epigenetic modification and cancer radiotherapy and briefly introduces the main types, mechanisms and applications of epigenetic modifiers used for radiotherapy sensitization in order to explore a more individual and dynamic approach of cancer treatment based on epigenetic mechanism. This study strives to make a modest contribution to the progress of human disease research.
format Online
Article
Text
id pubmed-9145982
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91459822022-05-29 The Advances in Epigenetics for Cancer Radiotherapy Wang, Yuexuan Han, Yu Jin, Yuzhen He, Qiang Wang, Zhicheng Int J Mol Sci Review Cancer is an important factor threatening human life and health; in recent years, its morbidity and mortality remain high and demosntrate an upward trend. It is of great significance to study its pathogenesis and targeted therapy. As the complex mechanisms of epigenetic modification has been increasingly discovered, they are more closely related to the occurrence and development of cancer. As a reversible response, epigenetic modification is of great significance for the improvement of classical therapeutic measures and the discovery of new therapeutic targets. It has become a research focusto explore the multi-level mechanisms of RNA, DNA, chromatin and proteins. As an important means of cancer treatment, radiotherapy has made great progress in technology, methods, means and targeted sensitization after years of rapid development, and even research on radiotherapy based on epigenetic modification is rampant. A series of epigenetic effects of radiation on DNA methylation, histone modification, chromosome remodeling, RNA modification and non-coding RNA during radiotherapy affects the therapeutic effects and prognosis. Starting from the epigenetic mechanism of tumorigenesis, this paper reviews the latest progress in the mechanism of interaction between epigenetic modification and cancer radiotherapy and briefly introduces the main types, mechanisms and applications of epigenetic modifiers used for radiotherapy sensitization in order to explore a more individual and dynamic approach of cancer treatment based on epigenetic mechanism. This study strives to make a modest contribution to the progress of human disease research. MDPI 2022-05-18 /pmc/articles/PMC9145982/ /pubmed/35628460 http://dx.doi.org/10.3390/ijms23105654 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Wang, Yuexuan
Han, Yu
Jin, Yuzhen
He, Qiang
Wang, Zhicheng
The Advances in Epigenetics for Cancer Radiotherapy
title The Advances in Epigenetics for Cancer Radiotherapy
title_full The Advances in Epigenetics for Cancer Radiotherapy
title_fullStr The Advances in Epigenetics for Cancer Radiotherapy
title_full_unstemmed The Advances in Epigenetics for Cancer Radiotherapy
title_short The Advances in Epigenetics for Cancer Radiotherapy
title_sort advances in epigenetics for cancer radiotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145982/
https://www.ncbi.nlm.nih.gov/pubmed/35628460
http://dx.doi.org/10.3390/ijms23105654
work_keys_str_mv AT wangyuexuan theadvancesinepigeneticsforcancerradiotherapy
AT hanyu theadvancesinepigeneticsforcancerradiotherapy
AT jinyuzhen theadvancesinepigeneticsforcancerradiotherapy
AT heqiang theadvancesinepigeneticsforcancerradiotherapy
AT wangzhicheng theadvancesinepigeneticsforcancerradiotherapy
AT wangyuexuan advancesinepigeneticsforcancerradiotherapy
AT hanyu advancesinepigeneticsforcancerradiotherapy
AT jinyuzhen advancesinepigeneticsforcancerradiotherapy
AT heqiang advancesinepigeneticsforcancerradiotherapy
AT wangzhicheng advancesinepigeneticsforcancerradiotherapy